Overview

Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression

Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
0
Participant gender:
All
Summary
Brief Summary: Purpose of this study is to evaluate efficacy of hydroxychloroquine (HCQ) in reducing progression of Corona Virus Disease 2019 (COVID - 19) and achieving viral clearance. Condition or disease :I COVID-19 ntervention/treatment :Drug: Hydroxychloroquine Sulfate Phase: Phase III
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UNICEF
Collaborators:
Pak Emirates Military Hospital Rawalpindi
Pak Emirates Military Hospital Rawalpindi, Pakistan
Criteria
Inclusion Criteria:

- Mild Corona virus disease (COVID-19)

- PCR confirmed infection

- Hospital admitted patients

Exclusion Criteria:

- Moderate, severe and critical COVID-19

- day 0 CRP greater than 6mg/dl, ALC < 1000 or evidence of infiltrates on X-ray chest

- comorbidity with life expectancy less than 6 months

- Contraindications to HCQ therapy